Stay up to date with notifications from The Independent

Notifications can be managed in browser preferences.

Indonesia's top Islamic body OKs China's Sinovac vaccine

Indonesia’s highest Islamic body has given its religious approval to China’s Sinovac vaccine, paving the way for its distribution in the world’s most populous Muslim nation

Via AP news wire
Friday 08 January 2021 10:44 GMT
Virus Outbreak Indonesia
Virus Outbreak Indonesia (Copyright 2021 The Associated Press. All rights reserved.)

Your support helps us to tell the story

From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.

At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.

The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.

Your support makes all the difference.

Indonesia's highest Islamic body has given its religious approval to China s Sinovac vaccine, paving the way for its distribution in the world's most populous Muslim nation.

The Indonesian Ulema Council on Friday announced that the COVID-19 vaccine is holy and halal, or fit for consumption by Muslims.

The head of the council's Fatwa Department Asorirun Niam Sholeh also said that the complete fatwa, or religious edict, related to the safety of the vaccine is still waiting for the green light from the Indonesian Food and Drug Authority.

The drug regulator said it would draw from data of the clinical trials in Brazil and Turkey, as well as own trial results before authorizing use of the vaccine.

Thank you for registering

Please refresh the page or navigate to another page on the site to be automatically logged inPlease refresh your browser to be logged in